Award
NIH Reporter #5R01CA243085-06
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
Recipient
Weill Medical College of Cornell University, New York, NY, United States
Award Amount
$317,911.00
Ceiling
$317,911.00
Awarded
May 22, 2025
Identifier
5R01CA243085-06
This award supports the development of advanced imaging nanoparticles for intraoperative detection and characterization of high-risk prostate cancer, aiming to improve surgical outcomes through precise tumor visualization and molecular targeting.
Description
Development of clinically-translatable ultrasmall particle imaging technologies to visualize local disease extent and molecularly characterize tumors in vivo by targeting multiple molecular signatures for improved surgical treatment of high-risk prostate cancer.